cbdMD announced plans to acquire the Twinlab supplement brands. The transaction is expected to add $30M in revenue.
Further details about the acquisition terms or integration plans were not immediately available.


The move aims to expand cbdMD's product portfolio in the supplements market.

cbdMD announced plans to acquire the Twinlab supplement brands. The transaction is expected to add $30M in revenue.
Further details about the acquisition terms or integration plans were not immediately available.

Lucas covers M&A activity and startup funding rounds, tracking deal structures and valuations to explain what a transaction means for the companies and markets involved.
More from Lucas Ferreira →

